| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | MYGN Myriad Genetics Inc | Lambert Nicole71 | Chief Operating Officer | Sell | 13,184 | $22.74 | $299,822.62 | -5.8% | -3.7% | -3.1% | |
| Mar 2, 2023 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 9,312 | $55.96 | $521,058.59 | -1.3% | -16.6% | +58.3% | |
| Mar 2, 2023 | XGN Exagen Inc. | Hazeltine Mark | Chief Business Officer | Sell | 3,667 | $0.00 | - | -1.9% | +27.5% | -14.4% | |
| Mar 2, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 40,835 | $55.00 | $2,245,925.00 | -16.6% | -16.6% | +58.3% | |
| Mar 2, 2023 | MTD Mettler Toledo International Inc/ | Chu Wah-Hui63 | Director | Sell | 300 | $1,450.00 | $435,000.00 | -6.5% | -10.7% | -14.3% | |
| Mar 2, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,819 | $15.88 | $44,757.83 | -0.5% | -25.9% | +11.6% | |
| Mar 2, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 10,397 | $0.45 | $4,662.01 | -26.7% | -49.9% | -43.2% | |
| Mar 1, 2023 | MTD Mettler Toledo International Inc/ | Filliol Olivier A71 | Director | Sell | 10,000 | $1,425.43 | $14,254,296.14 | -14.2% | -7.3% | -12.0% | |
| Mar 1, 2023 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 1,000 | $62.00 | $62,000.00 | -1.1% | +29.9% | -7.9% | |
| Mar 1, 2023 | EXAS Exact Sciences Corp | Cunningham Everett54 | Chief Commercial Officer | Sell | 3,628 | $62.01 | $224,972.28 | -13.8% | +29.9% | -7.9% | |
| Feb 28, 2023 | MTD Mettler Toledo International Inc/ | Filliol Olivier A71 | Director | Sell | 10,000 | $1,433.61 | $14,336,083.11 | -18.4% | -8.3% | -13.3% | |
| Feb 28, 2023 | VCYT Veracyte, Inc. | Eastham Karin67 | Director | Sell | 10,000 | $25.00 | $250,001.00 | -29.9% | +4.3% | -3.4% | |
| Feb 28, 2023 | WAT Waters Corp /de/ | Vergnano Mark P47 | Director | Buy | 3,185 | $313.32 | $997,927.39 | +856.2% | -17.8% | +8.6% | |
| Feb 28, 2023 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 5,498 | $48.94 | $269,066.07 | -2.9% | -3.0% | +57.7% | |
| Feb 28, 2023 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 2,924 | $61.12 | $178,714.88 | -3.2% | +30.2% | -9.7% | |
| Feb 28, 2023 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 10,416 | $61.12 | $636,625.92 | -0.9% | +30.2% | -9.7% | |
| Feb 28, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 13,474 | $48.94 | $659,402.74 | -5.2% | -3.0% | +57.7% | |
| Feb 28, 2023 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, Screening | Sell | 6,832 | $60.29 | $411,871.84 | -16.5% | +30.2% | -9.7% | |
| Feb 28, 2023 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 4,233 | $61.12 | $258,720.96 | -12.6% | +30.2% | -9.7% | |
| Feb 28, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 5,218 | $48.94 | $255,363.18 | -7.7% | -3.0% | +57.7% | |
| Feb 28, 2023 | EXAS Exact Sciences Corp | Coward D Scott77 | Director | Sell | 4,153 | $61.12 | $253,831.36 | -11.2% | +30.2% | -9.7% | |
| Feb 28, 2023 | EXAS Exact Sciences Corp | Baranick Brian75 | Gen. Mgr., Precision Oncology | Sell | 1,932 | $61.12 | $118,083.84 | -20.5% | +30.2% | -9.7% | |
| Feb 28, 2023 | EXAS Exact Sciences Corp | Herriott James75 | General Counsel | Sell | 2,225 | $60.43 | $134,453.00 | -10.3% | +30.2% | -9.7% | |
| Feb 28, 2023 | TTOO T2 Biosystems, Inc. | Sperzel John J III | Chairman And CEO | Sell | 9,773 | $0.63 | $6,178.57 | -24.0% | - | - | |
| Feb 28, 2023 | TTOO T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Sell | 3,730 | $0.62 | $2,329.40 | -24.2% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.